Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs.

Pombo-Suarez M, Gomez-Reino J.

Pharmacol Res. 2019 Aug 25;148:104410. doi: 10.1016/j.phrs.2019.104410. [Epub ahead of print] Review.

PMID:
31461667
2.

Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment.

Genovese MC, van der Heijde D, Lin Y, St John G, Wang S, van Hoogstraten H, Gómez-Reino JJ, Kivitz A, Maldonado-Cocco JA, Seriolo B, Stanislav M, Burmester GR.

RMD Open. 2019 Aug 1;5(2):e000887. doi: 10.1136/rmdopen-2018-000887. eCollection 2019.

3.

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, Kristianslund EK, Nordström D, Santos MJ, Codreanu C, Gómez-Reino J, Rotar Z, Gudbjornsson B, Di Giuseppe D, Nissen MJ, Pavelka K, Birlik M, Kvien T, Eklund KK, Barcelos A, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Loft AG, van der Horst-Bruinsma I, Jones G, Iannone F, Hyldstrup L, Krogh NS, Hetland ML, Østergaard M.

Ann Rheum Dis. 2019 Aug 20. pii: annrheumdis-2019-215427. doi: 10.1136/annrheumdis-2019-215427. [Epub ahead of print]

PMID:
31431486
4.

Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.

Fleischmann R, Genovese MC, Lin Y, St John G, van der Heijde D, Wang S, Gomez-Reino JJ, Maldonado-Cocco JA, Stanislav M, Kivitz AJ, Burmester GR.

Rheumatology (Oxford). 2019 Jul 15. pii: kez265. doi: 10.1093/rheumatology/kez265. [Epub ahead of print]

PMID:
31312844
5.

Visfatin as a therapeutic target for rheumatoid arthritis.

Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, Jorge-Mora A, Gualillo O, Gómez-Reino JJ, Gómez Bahamonde R.

Expert Opin Ther Targets. 2019 Jul;23(7):607-618. doi: 10.1080/14728222.2019.1617274. Epub 2019 May 15.

PMID:
31074669
6.

Update of the Position Paper of the Spanish Society of Rheumatology on Biosimilar Drugs.

Abad Hernández MÁ, Andreu JL, Balsa Criado A, Díaz-González F, Moreno Muelas JV, Queiro Silva R, Gómez-Reino JJ.

Reumatol Clin. 2019 May 1. pii: S1699-258X(19)30059-2. doi: 10.1016/j.reuma.2019.03.007. [Epub ahead of print] English, Spanish.

7.

Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR.

Ranza R, de la Vega MC, Laurindo IMM, Gómez MG, Titton DC, Kakehasi AM, Brigante A, Benitez A, Ranzolin A, Granel A, Cappuccio AM, Quinteros A, Hayata ALS, Smichowski A, Duarte ÂLBP, Kahlow BS, Andia CS, Brenol CV, Velozo E, Mussano E, Soriano ER, Christopoulos GB, da Rocha Castelar Pinheiro G, de Castro GRW, Casado G, da Silveira Carvalho HM, Exeni IE, da Silveira IG, Petkovic I, Pereira IA, da Costa IP, Rosa JE, Miranda JRS, de Moraes JCB, Bertolo MB, Buhl M, Lázaro MA, da Sauma MFLC, de Medeiros Pinheiro M, Díaz M, de Vechi MVSS, Cerda OL, Astesana P, Curi PF, Louzada-Jr P, Teodoro RB, Toledo RA, Papasidero S, Valim V, Fernandes V, Saurit V, Bianchi WA; BIOBADABRASIL study group, Sociedade Brasileira de Reumatologia and of the BIOBADASAR study group, Sociedad Argentina de Reumatologia, de Melo Costa Pinto R, Descalzo MA, Gomez-Reino JJ.

Clin Rheumatol. 2019 Aug;38(8):2129-2139. doi: 10.1007/s10067-019-04516-2. Epub 2019 Apr 17.

PMID:
31016578
8.

Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.

Ferreiro-Iglesias A, Montes A, Perez-Pampin E, Cañete JD, Raya E, Magro-Checa C, Vasilopoulos Y, Caliz R, Ferrer MA, Joven B, Carreira P, Balsa A, Pascual-Salcedo D, Blanco FJ, Moreno-Ramos MJ, Manrique-Arija S, Ordoñez MDC, Alegre-Sancho JJ, Narvaez J, Navarro-Sarabia F, Moreira V, Valor L, Garcia-Portales R, Marquez A, Gomez-Reino JJ, Martin J, Gonzalez A.

PLoS One. 2019 Feb 28;14(2):e0213073. doi: 10.1371/journal.pone.0213073. eCollection 2019.

9.

Abatacept for the treatment of rheumatoid arthritis.

Pombo-Suarez M, Gomez-Reino JJ.

Expert Rev Clin Immunol. 2019 Apr;15(4):319-326. doi: 10.1080/1744666X.2019.1579642. Epub 2019 Feb 18.

PMID:
30730220
10.

Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies.

Nash P, Coates LC, Fleischmann R, Papp KA, Gomez-Reino JJ, Kanik KS, Wang C, Wu J, Menon S, Hendrikx T, Ports WC.

Rheumatol Ther. 2018 Dec;5(2):567-582. doi: 10.1007/s40744-018-0131-5. Epub 2018 Nov 9.

11.

Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.

Hernandez MV, Sanchez-Piedra C, Garcia-Magallon B, Cuende E, Manero J, Campos-Fernandez C, Martin-Domenech R, Del Pino-Montes J, Manrique S, Castro-Villegas MC, Ruiz-Montesinos D, Sanchez-Alonso F, Diaz-Gonzalez F, Cea-Calvo L, Gómez-Reino JJ; BIOBADASER Study Group.

Rheumatol Int. 2019 Mar;39(3):509-515. doi: 10.1007/s00296-018-4177-z. Epub 2018 Oct 24.

PMID:
30353269
12.

Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.

Bethencourt Baute JJ, Sanchez-Piedra C, Ruiz-Montesinos D, Medrano San Ildefonso M, Rodriguez-Lozano C, Perez-Pampin E, Ortiz A, Manrique S, Roselló R, Hernandez V, Campos C, Sellas A, Sifuentes-Giraldo WA, García-González J, Sanchez-Alonso F, Díaz-González F, Gómez-Reino JJ, Bustabad Reyes S; BIOBADASER study group.

Arthritis Res Ther. 2018 Oct 10;20(1):227. doi: 10.1186/s13075-018-1728-3.

13.

Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.

Regueiro C, Rodriguez-Rodriguez L, Triguero-Martinez A, Nuño L, Castaño-Nuñez AL, Villalva A, Perez-Pampin E, Lopez-Golan Y, Abasolo L, Ortiz AM, Herranz E, Pascual-Salcedo D, Martínez-Feito A, Boveda MD, Gomez-Reino JJ, Martín J, Gonzalez-Escribano MF, Fernandez-Gutierrez B, Balsa A, Gonzalez-Alvaro I, Gonzalez A.

Arthritis Rheumatol. 2019 Mar;71(3):331-339. doi: 10.1002/art.40738. Epub 2019 Jan 28.

PMID:
30277011
14.

Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial.

Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Perez-Pampin E, Romo Lopez A, Rodríguez Alvarez FM, Castillo Laguarta JM, Del Estad Cabello A, Gessa Sorroche M, España Gregori E, Sales-Sanz M; Tocilizumab in Graves Orbitopathy Study Group.

Am J Ophthalmol. 2018 Nov;195:181-190. doi: 10.1016/j.ajo.2018.07.038. Epub 2018 Aug 4.

PMID:
30081019
15.

Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies.

Gladman DD, Kavanaugh A, Gómez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, Guerette B, Delev N, Teng L, Edwards CJ, Birbara CA, Mease PJ.

RMD Open. 2018 Jun 27;4(1):e000669. doi: 10.1136/rmdopen-2018-000669. eCollection 2018.

16.

Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis.

López-Rodríguez R, Ferreiro-Iglesias A, Lima A, Bernardes M, Pawlik A, Paradowska-Gorycka A, Świerkot J, Slezak R, Dolžan V, González-Álvaro I, Narváez J, Cáliz R, Pérez-Pampín E, Mera-Varela A, Vidal-Bralo L, Acuña Ochoa JG, Conde C, Gómez-Reino JJ, González A.

Sci Rep. 2018 May 9;8(1):7342. doi: 10.1038/s41598-018-25634-y.

17.

Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.

Lopez-Rodriguez R, Perez-Pampin E, Marquez A, Blanco FJ, Joven B, Carreira P, Ferrer MA, Caliz R, Valor L, Narvaez J, Cañete JD, Ordoñez MDC, Manrique-Arija S, Vasilopoulos Y, Balsa A, Pascual-Salcedo D, Moreno-Ramos MJ, Alegre-Sancho JJ, Navarro-Sarabia F, Moreira V, Garcia-Portales R, Raya E, Magro-Checa C, Martin J, Gomez-Reino JJ, Gonzalez A.

PLoS One. 2018 May 7;13(5):e0196793. doi: 10.1371/journal.pone.0196793. eCollection 2018.

18.

Correction to: Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology.

Salgado E, Maneiro Fernández JR, Souto Vilas A, Gómez-Reino JJ.

Rheumatol Int. 2018 May;38(5):933. doi: 10.1007/s00296-018-4015-3.

PMID:
29594329
19.

Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment.

Taylor PC, Alten R, Gomez-Reino JJ, Caporali R, Bertin P, Sullivan E, Wood R, Piercy J, Vasilescu R, Spurden D, Alvir J, Tarallo M.

RMD Open. 2018 Mar 17;4(1):e000615. doi: 10.1136/rmdopen-2017-000615. eCollection 2018.

20.

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents).

Baddley JW, Cantini F, Goletti D, Gómez-Reino JJ, Mylonakis E, San-Juan R, Fernández-Ruiz M, Torre-Cisneros J.

Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S10-S20. doi: 10.1016/j.cmi.2017.12.025. Epub 2018 Feb 6. Review.

21.

Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology.

Salgado E, Maneiro Fernández JR, Souto Vilas A, Gómez-Reino JJ.

Rheumatol Int. 2018 Mar;38(3):467-472. doi: 10.1007/s00296-018-3930-7. Epub 2018 Jan 22. Erratum in: Rheumatol Int. 2018 Mar 29;:.

PMID:
29356882
22.

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE).

Nash P, Ohson K, Walsh J, Delev N, Nguyen D, Teng L, Gómez-Reino JJ, Aelion JA; ACTIVE investigators.

Ann Rheum Dis. 2018 May;77(5):690-698. doi: 10.1136/annrheumdis-2017-211568. Epub 2018 Jan 17.

23.

Status of Rheumatology in Spain in 2017: 2.0 Rheumatologists per 100,000 Population.

Sanchez-Piedra C, Yoldi B, Valero M, Andreu JL, Díaz-González F, Gómez-Reino JJ; en representación del Grupo de trabajo BIOBADASER Fase III.

Reumatol Clin. 2018 Sep - Oct;14(5):311-312. doi: 10.1016/j.reuma.2017.10.003. Epub 2017 Nov 11. English, Spanish. No abstract available.

24.

Objectives and methodology of BIOBADASER phase iii.

Sanchez-Piedra C, Hernández Miguel MV, Manero J, Roselló R, Sánchez-Costa JT, Rodríguez-Lozano C, Campos C, Cuende E, Fernández-Lopez JC, Bustabad S, Martín Domenech R, Pérez-Pampín E, Del Pino-Montes J, Millan-Arciniegas AM, Díaz-González F, Gómez-Reino JJ; en representación del Grupo de trabajo BIOBADASER Fase III.

Reumatol Clin. 2019 Jul - Aug;15(4):229-236. doi: 10.1016/j.reuma.2017.08.001. Epub 2017 Sep 19. English, Spanish.

25.

Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients.

Vidal-Bralo L, Perez-Pampin E, Regueiro C, Montes A, Varela R, Boveda MD, Gomez-Reino JJ, Gonzalez A.

PLoS One. 2017 Jul 3;12(7):e0180144. doi: 10.1371/journal.pone.0180144. eCollection 2017.

26.

A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.

Smolen JS, Cohen SB, Tony HP, Scheinberg M, Kivitz A, Balanescu A, Gomez-Reino J, Cen L, Zhu P, Shisha T.

Ann Rheum Dis. 2017 Sep;76(9):1598-1602. doi: 10.1136/annrheumdis-2017-211281. Epub 2017 Jun 21.

27.

Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis.

Maneiro JR, Souto A, Gomez-Reino JJ.

Semin Arthritis Rheum. 2017 Oct;47(2):149-156. doi: 10.1016/j.semarthrit.2017.02.007. Epub 2017 Feb 16. Review.

PMID:
28284845
28.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Review.

29.

Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis.

Maneiro JR, Souto A, Gomez-Reino JJ.

Clin Rheumatol. 2017 May;36(5):1167-1172. doi: 10.1007/s10067-017-3537-5. Epub 2017 Jan 20.

PMID:
28108800
30.

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration.

Chatzidionysiou K, Lie E, Lukina G, Hetland ML, Hauge EM, Pavelka K, Gabay C, Scherer A, Nordström D, Canhao H, Santos MJ, Tomsic M, Rotar Z, Hernández MV, Gomez-Reino J, Ancuta I, Kvien TK, van Vollenhoven R.

J Rheumatol. 2017 Feb;44(2):162-169. doi: 10.3899/jrheum.160460. Epub 2017 Jan 15.

PMID:
28089978
31.

Leptin in the interplay of inflammation, metabolism and immune system disorders.

Abella V, Scotece M, Conde J, Pino J, Gonzalez-Gay MA, Gómez-Reino JJ, Mera A, Lago F, Gómez R, Gualillo O.

Nat Rev Rheumatol. 2017 Feb;13(2):100-109. doi: 10.1038/nrrheum.2016.209. Epub 2017 Jan 5. Review.

PMID:
28053336
32.

Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study.

Jones G, Wallace T, McIntosh MJ, Brockwell L, Gómez-Reino JJ, Sebba A.

J Rheumatol. 2017 Feb;44(2):142-146. doi: 10.3899/jrheum.160287. Epub 2016 Dec 1.

33.

Specific premature epigenetic aging of cartilage in osteoarthritis.

Vidal-Bralo L, Lopez-Golan Y, Mera-Varela A, Rego-Perez I, Horvath S, Zhang Y, Del Real Á, Zhai G, Blanco FJ, Riancho JA, Gomez-Reino JJ, Gonzalez A.

Aging (Albany NY). 2016 Sep 28;8(9):2222-2231. doi: 10.18632/aging.101053.

34.

Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis.

Choy E, Aletaha D, Behrens F, Finckh A, Gomez-Reino J, Gottenberg JE, Schuch F, Rubbert-Roth A.

Rheumatology (Oxford). 2017 May 1;56(5):689-697. doi: 10.1093/rheumatology/kew271. Review.

PMID:
27550301
35.

Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies.

Montes A, Regueiro C, Perez-Pampin E, Boveda MD, Gomez-Reino JJ, Gonzalez A.

PLoS One. 2016 Aug 18;11(8):e0161141. doi: 10.1371/journal.pone.0161141. eCollection 2016.

36.

Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient.

Scotece M, Pérez T, Conde J, Abella V, López V, Pino J, Gonzalez-Gay MA, Gomez-Reino JJ, Mera A, Gomez R, Gualillo O.

J Orthop Res. 2017 Jun;35(6):1299-1303. doi: 10.1002/jor.23377. Epub 2017 Mar 28.

37.

Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration.

Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Ancuta I, Pavelka K, Nordström DC, Gabay C, Canhão H, Tomsic M, van Riel PL, Gomez-Reino J, Kvien TK, van Vollenhoven RF.

Arthritis Res Ther. 2016 Jun 20;18(1):144. No abstract available.

38.

Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.

Martin-Mola E, Balsa A, García-Vicuna R, Gómez-Reino J, González-Gay MA, Sanmartí R, Loza E.

Rheumatol Int. 2016 Aug;36(8):1043-63. doi: 10.1007/s00296-016-3506-3. Epub 2016 Jun 6. Review.

PMID:
27271502
39.

Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials.

Wallenstein GV, Kanik KS, Wilkinson B, Cohen S, Cutolo M, Fleischmann RM, Genovese MC, Gomez Reino J, Gruben D, Kremer J, Krishnaswami S, Lee EB, Pascual-Ramos V, Strand V, Zwillich SH.

Clin Exp Rheumatol. 2016 May-Jun;34(3):430-42. Epub 2016 Apr 28.

40.

Therapy: The NICE position on indications for biologics and biosimilars.

Scheinberg M, Gomez-Reino JJ.

Nat Rev Rheumatol. 2016 May;12(5):255-6. doi: 10.1038/nrrheum.2016.56. Epub 2016 Apr 15. Review. No abstract available.

PMID:
27080695
41.

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.

Ortea I, Roschitzki B, López-Rodríguez R, Tomero EG, Ovalles JG, López-Longo J, de la Torre I, González-Alvaro I, Gómez-Reino JJ, González A.

PLoS One. 2016 Apr 6;11(4):e0153140. doi: 10.1371/journal.pone.0153140. eCollection 2016.

42.

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration.

Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Ancuta I, Pavelka K, Nordström DC, Gabay C, Canhão H, Tomsic M, van Riel PL, Gomez-Reino J, Kvien TK, van Vollenhoven RF; Rheumatic Diseases Portuguese Register.

Arthritis Res Ther. 2016 Feb 16;18:50. doi: 10.1186/s13075-016-0951-z. Erratum in: Arthritis Res Ther. 2016;18(1):144.

43.

The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.

Abella V, Scotece M, Conde J, Gómez R, Lois A, Pino J, Gómez-Reino JJ, Lago F, Mobasheri A, Gualillo O.

Biomarkers. 2015;20(8):565-71. doi: 10.3109/1354750X.2015.1123354. Epub 2015 Dec 15. Review.

44.

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials.

Strand V, Ahadieh S, French J, Geier J, Krishnaswami S, Menon S, Checchio T, Tensfeldt TG, Hoffman E, Riese R, Boy M, Gómez-Reino JJ.

Arthritis Res Ther. 2015 Dec 15;17:362. doi: 10.1186/s13075-015-0880-2. Review.

45.

IL-36α: a novel cytokine involved in the catabolic and inflammatory response in chondrocytes.

Conde J, Scotece M, Abella V, Lois A, López V, García-Caballero T, Pino J, Gómez-Reino JJ, Gómez R, Lago F, Gualillo O.

Sci Rep. 2015 Nov 12;5:16674. doi: 10.1038/srep16674.

46.

The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region.

Mariette X, Vencovsky J, Lortholary O, Gomez-Reino J, de Longueville M, Ralston P, Weinblatt M, van Vollenhoven R.

RMD Open. 2015 Apr 28;1(1):e000044. doi: 10.1136/rmdopen-2014-000044. eCollection 2015.

47.

Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis.

Maneiro JR, Souto A, Salgado E, Mera A, Gomez-Reino JJ.

RMD Open. 2015 Feb 18;1(1):e000017. doi: 10.1136/rmdopen-2014-000017. eCollection 2015.

48.

Apremilast for the treatment of psoriatic arthritis.

Souto A, Gómez-Reino JJ.

Expert Rev Clin Immunol. 2015;11(12):1281-90. doi: 10.1586/1744666X.2015.1102057. Epub 2015 Oct 26. Review.

PMID:
26503917
49.

Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases.

Souto A, Maneiro JR, Gómez-Reino JJ.

Rheumatology (Oxford). 2016 Mar;55(3):523-34. doi: 10.1093/rheumatology/kev374. Epub 2015 Oct 21. Review.

PMID:
26490106
50.

High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort.

Salgado E, Bes-Rastrollo M, de Irala J, Carmona L, Gómez-Reino JJ.

Medicine (Baltimore). 2015 Sep;94(37):e924. doi: 10.1097/MD.0000000000000924.

Supplemental Content

Loading ...
Support Center